Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 6/20 | 0.36 |
| ▸ | RAB9A | P51151 | 6/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 6/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | PKM | P14618 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | CDK2 | P24941 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.32 |
| ▸ | NOS3 | P29474 | 1/20 | 0.32 |
| ▸ | NOS1 | P29475 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | NAMPT | P43490 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL211479 | 0.66 | — | — | |
| SCHEMBL17350606 | 0.66 | — | — | |
| Hydrochloric Acid SCHEMBL1641189 | 0.65 | — | — | |
| SCHEMBL22098290 | 0.63 | HCAR2 (0.40) | HCAR2NPC1RAB9AALOX15SMN1; SMN2 | |
| SCHEMBL12705122 | 0.63 | HCAR2 (0.59) | HCAR2NPC1RAB9AALOX15SMN1; SMN2 | |
| SCHEMBL21092332 | 0.62 | HCAR2 (0.39) | HCAR2NPC1RAB9AALOX15SMN1; SMN2 | |
| SCHEMBL19278355 | 0.61 | KDM4E (0.46) | NPC1RAB9ASMN1; SMN2KMT2AMAPT | |
| SCHEMBL9235646 | 0.59 | HTT (0.36) | NPC1RAB9ASMN1; SMN2KMT2AMEN1 | |
| SCHEMBL2889027 | 0.59 | — | — | |
| SCHEMBL40333 | 0.59 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230053347-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-02-23 | — | — | US | disclosed |
| US-20200044163-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2020-02-06 | — | — | US | disclosed |
| US-9911931-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2018-03-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200044163-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | NME4, TERT, TERF2IP | HCAR2 4451/4885NPC1 2609/4885RAB9A 438/4885 |
| US-20230053347-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | SOD1, CLTB, L1CAM | HCAR2 4209/4885NPC1 3824/4885RAB9A 2330/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.